Marketing-authorisation holder · Singapore
Takeda Pharmaceuticals (Asia Pacific) Pte. Ltd.
50 medicines in 1 country, as authorisation holder.
Loading your page…
Loading your page…
Marketing-authorisation holder · Singapore
50 medicines in 1 country, as authorisation holder.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 50
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ADCETRIS® POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 50MG/VIAL50mg/vial · Injection, powder, for solution | Brentuximab vedotin | Singapore | Authorised | 2014 |
| ADVATE 1000 IU Powder and Solvent for Solution for Injection1000 iu · Injection, powder, lyophilized, for solution | Antihemophilic factor | Singapore | Authorised | 2008 |
| ADVATE 1500 IU Powder and Solvent for Solution for Injection1500 iu · Injection, powder, lyophilized, for solution | Antihemophilic factor | Singapore | Authorised | 2008 |
| ADVATE 250 IU Powder and Solvent for Solution for Injection250 iu · Injection, powder, lyophilized, for solution | Antihemophilic factor | Singapore | Authorised | 2008 |
| ADVATE 500 IU Powder and Solvent for Solution for Injection500 iu · Injection, powder, lyophilized, for solution | Antihemophilic factor | Singapore | Authorised | 2008 |
| ADYNOVATE 1000 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION1000 iu · Injection, powder, lyophilized, for solution | Antihemophilic factor | Singapore | Authorised | 2020 |
| ADYNOVATE 1500 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION1500 iu · Injection, powder, lyophilized, for solution | Antihemophilic factor | Singapore | Authorised | 2020 |
| ADYNOVATE 2000 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION2000 iu · Injection, powder, lyophilized, for solution | Antihemophilic factor | Singapore | Authorised | 2020 |
| ADYNOVATE 250 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION250 iu · Injection, powder, lyophilized, for solution | Antihemophilic factor | Singapore | Authorised | 2020 |
| ADYNOVATE 3000 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION3000 iu · Injection, powder, lyophilized, for solution | Antihemophilic factor | Singapore | Authorised | 2020 |
| ADYNOVATE 500 IU POWDER AND SOLVENT FOR SOLUTION FOR INJECTION500 iu · Injection, powder, lyophilized, for solution | Antihemophilic factor | Singapore | Authorised | 2020 |
| AGRYLIN CAPSULE 0.5 mg0.61mg · Capsule | Anagrelide | Singapore | Authorised | 2004 |
| ALUNBRIG FILM-COATED TABLET 180mg180mg · Tablet, film coated | Brigatinib | Singapore | Authorised | 2019 |
| ALUNBRIG FILM-COATED TABLET 30mg30mg · Tablet, film coated | Brigatinib | Singapore | Authorised | 2019 |
| ALUNBRIG FILM-COATED TABLET 90mg90mg · Tablet, film coated | Brigatinib | Singapore | Authorised | 2019 |
| ALUNBRIG INITIATION PACK180.00mg + 90mg · Tablet, film coated | Brigatinib | Singapore | Authorised | 2019 |
| CONTROLOC IV INJECTION 40 mg/vial40 mg/vial · Injection | Pantoprazole | Singapore | Authorised | 1999 |
| CONTROLOC TABLET 20 mg20 mg · Enteric coated tablet | Pantoprazole | Singapore | Authorised | 1999 |
| CONTROLOC TABLET 40 mg40 mg · Enteric coated tablet | Pantoprazole | Singapore | Authorised | 1996 |
| DEXILANT DELAYED RELEASE CAPSULE 30mg30mg · Capsule, delayed release | Dexlansoprazole | Singapore | Authorised | 2014 |
| DEXILANT DELAYED RELEASE CAPSULE 60mg60mg · Capsule, delayed release | Dexlansoprazole | Singapore | Authorised | 2014 |
| ENTYVIO POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 300MG/VIAL300 mg/vial · Injection, powder, for solution | Vedolizumab | Singapore | Authorised | 2016 |
| ENTYVIO SOLUTION FOR INJECTION IN PRE-FILLED PEN 108MG/0.68ML108mg/0.68mL · Injection, solution | Vedolizumab | Singapore | Authorised | 2023 |
| FEIBA 1000 U50 u/ml · Injection, powder, for solution | Factor viii inhibitor bypassing activity | Singapore | Authorised | 1999 |
| FEIBA 500 U25 u/ml · Injection, powder, for solution | Factor viii inhibitor bypassing activity | Singapore | Authorised | 1999 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Singapore | 50 | 50 | 0 | CompaniesAll medicines |
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Contains information from HSA Listing of Registered Therapeutic Products accessed on 8 October 2026 from data.gov.sg, under Singapore Open Data Licence 1.0: https://data.gov.sg/open-data-licence
Licence: Singapore Open Data Licence
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.